Why Hemophilia Patients Could Pay $1.5 Million For Gene Therapy – Investor’s Business Daily
Endpoints News |
Why Hemophilia Patients Could Pay $1.5 Million For Gene Therapy
Investor’s Business Daily Leerink analyst Joseph Schwartz boosted his projections for hemophilia gene therapies to $1.5 million from earlier assumptions for $350,000-$500,000 per patient. Some treatments could go as high as $2 million per patient on a gross basis, he said … US’s first drug priced at more than $1 million may be on the horizonCNBC Is biopharma’s first $1.5M therapy now in Phase III?Endpoints News |
ROI-NJ.com |
Hackensack Meridian joins NJII cell, gene therapy center
ROI-NJ.com The center provides technology and infrastructure to support cell therapy products, and training, education and workforce development solutions for cell and gene therapy companies. Dr. Haro Hartounian, center director and NJII’s executive director … |
Singularity Hub |
This New Startup Will Use CRISPR as a Search Engine to Hunt Down Diseases
Singularity Hub By now, you’ve heard of CRISPR—the bacterial self-defense mechanism that can be used to modify the genome. From “biohackers” building the hype by injecting themselves with CRISPR—and later regretting it—to the more measured, successful approach … |
Singularity Hub |
This New Startup Will Use CRISPR as a Search Engine to Hunt Down Diseases
Singularity Hub By now, you’ve heard of CRISPR—the bacterial self-defense mechanism that can be used to modify the genome. From “biohackers” building the hype by injecting themselves with CRISPR—and later regretting it—to the more measured, successful approach … |